Corvus Pharmaceuticals Long Term Deferred Assets (Quarterly) Analysis

Corvus Pharmaceuticals, Inc. (CRVS)

16.57 -0.96 (-5.48%) USD | NASDAQ | Feb 20, 16:00

16.53 -0.04 (-0.24%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
Plus Therapeutics, Inc.	--
Geron Corp.	--
Jaguar Health, Inc.	--
Krystal Biotech, Inc.	--